Fairmount Healthcare Fund L.P.
Insider CIK 1686157 · VRDN Director, 10% owner · SYRE Director, 10% owner · APGE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APGE Apogee Therapeutics, Inc. | J Other deriv | 2024-03-28 | 2024-04-01 | 221,426 | — | $0 | 6,743,321 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | J Other deriv | 2024-03-28 | 2024-04-01 | 221,426 | — | $0 | 0 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | J Other deriv | 2024-03-28 | 2024-04-01 | 21,999 | — | $0 | 0 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | J Other deriv | 2024-03-28 | 2024-04-01 | 21,999 | — | $0 | 133,191 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | J Other | 2024-03-28 | 2024-04-01 | 55,913 | — | $0 | 2,048,647 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | J Other | 2024-03-28 | 2024-04-01 | 55,913 | — | $0 | 0 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | J Other | 2024-03-28 | 2024-04-01 | 5,859 | — | $0 | 1,845,813 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | J Other | 2024-03-28 | 2024-04-01 | 5,859 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | J Other | 2024-01-29 | 2024-01-31 | 51,166 | — | $0 | 51,166 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | J Other | 2024-01-29 | 2024-01-31 | 892,529 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | J Other | 2024-01-29 | 2024-01-31 | 51,166 | — | $0 | 51,166 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | P Buy | 2024-01-22 | 2024-01-24 | 476,190 | $21.00 | $10.00M | 1,839,954 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | J Other | 2023-12-29 | 2023-12-29 | 3,435,480 | — | $0 | 0 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | J Other | 2023-12-29 | 2023-12-29 | 406,038 | — | $0 | 406,038 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | J Other | 2023-12-29 | 2023-12-29 | 406,038 | — | $0 | 406,038 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | A Award deriv | 2023-12-07 | 2023-12-11 | 16,667 | $600.00 | $10.00M | 16,667 | SEC↗ |
| AGLE Spyre Therapeutics, Inc. | C Conversion deriv | 2023-11-24 | 2023-11-28 | 85,887 | — | $0 | 0 | SEC↗ |
| AGLE Spyre Therapeutics, Inc. | C Conversion | 2023-11-24 | 2023-11-28 | 3,435,480 | — | $0 | 3,435,480 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2023-10-30 | 2023-11-01 | 48,463 | $825.37 | $40.00M | 48,463 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | A Award deriv | 2023-07-13 | 2023-07-17 | 47,758 | — | $0 | 47,758 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | A Award deriv | 2023-07-13 | 2023-07-17 | 47,758 | — | $0 | 47,758 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | P Buy | 2023-07-13 | 2023-07-17 | 892,529 | $17.00 | $15.17M | 892,529 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | P Buy | 2023-07-13 | 2023-07-17 | 1,992,734 | $17.00 | $33.88M | 1,992,734 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | P Buy | 2023-07-13 | 2023-07-17 | 55,913 | $17.00 | $950.5K | 55,913 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | P Buy | 2022-08-17 | 2022-08-19 | 425,531 | $23.50 | $10.00M | 1,363,764 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | P Buy | 2021-09-21 | 2021-09-23 | 909,000 | $11.00 | $10.00M | 938,233 | SEC↗ |
| MGEN MIRAGEN THERAPEUTICS, INC. | P Buy deriv | 2020-10-30 | 2020-10-30 | 5,494 | $465.96 | $2.56M | 21,999 | SEC↗ |
| MGEN MIRAGEN THERAPEUTICS, INC. | P Buy deriv | 2020-10-30 | 2020-10-30 | 28,843 | $465.96 | $13.44M | 111,192 | SEC↗ |
| MGEN MIRAGEN THERAPEUTICS, INC. | J Other deriv | 2020-10-27 | 2020-10-29 | 16,505 | — | $0 | 16,505 | SEC↗ |
| MGEN MIRAGEN THERAPEUTICS, INC. | J Other deriv | 2020-10-27 | 2020-10-29 | 82,349 | — | $0 | 82,349 | SEC↗ |
| MGEN MIRAGEN THERAPEUTICS, INC. | J Other | 2020-10-27 | 2020-10-29 | 438,502 | — | $0 | 438,502 | SEC↗ |
| MGEN MIRAGEN THERAPEUTICS, INC. | J Other | 2020-10-27 | 2020-10-29 | 87,891 | — | $0 | 87,891 | SEC↗ |